Summary
Updated Aug 31, 2026
Femida H. Gwadry-Sridhar is Director of Medpace Holdings, Inc. (MEDP). 1 SEC Form 4 filing on record, dated 18 May 2026.
Trading Pattern
InsiderAlpha's records for Femida H. Gwadry-Sridhar go back to 2026: 1 primary Form 4 filing, an average of 1.0 per year. No transaction on record carries a Rule 10b5-1 flag - the filings look discretionary rather than pre-scheduled, which makes their timing more informative as a signal.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Femida H. Gwadry-Sridhar files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- August J. Troendle - $249.99M of MEDP open-market activity in the last 12 months
- Jesse J. Geiger - $41.11M of MEDP open-market activity in the last 12 months
- Susan E. Burwig - $33.58M of MEDP open-market activity in the last 12 months
- Stephen P. Ewald - $16.48M of MEDP open-market activity in the last 12 months
- Fred B. Davenport Jr. - $7.89M of MEDP open-market activity in the last 12 months
- Robert O. Kraft - $6.21M of MEDP open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Femida H. Gwadry-Sridhar?
Femida H. Gwadry-Sridhar is a corporate insider, tracked as Director of Medpace Holdings, Inc. (MEDP). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did Femida H. Gwadry-Sridhar last file a Form 4?
The only primary Form 4 on record is dated 18 May 2026.
Where can I see all of Femida H. Gwadry-Sridhar's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Femida H. Gwadry-Sridhar and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial